The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials
J Infect
.
2021 Feb;82(2):282-327.
doi: 10.1016/j.jinf.2020.09.034.
Epub 2020 Sep 28.
Authors
Thibault Sixt
1
,
Florian Moretto
1
,
Hervé Devilliers
2
,
Maroua Abdallahoui
3
,
Isabelle Eberl
1
,
Thomas Rogier
3
,
Michel Duong
1
,
Arnaud Salmon-Rousseau
1
,
Sophie Mahy
1
,
Marielle Buisson
1
,
Clementine Esteve
1
,
Pascal Chavanet
4
,
François-Xavier Catherine
1
,
Mathieu Blot
4
,
Lionel Piroth
5
Affiliations
1
Infectious Diseases Department, Dijon University Hospital, France.
2
Internal medicine department, Dijon University Hospital, France; INSERM CIC 1432, module plurithématique, University of Burgundy, Dijon, France.
3
Internal medicine department, Dijon University Hospital, France.
4
Infectious Diseases Department, Dijon University Hospital, France; INSERM CIC 1432, module plurithématique, University of Burgundy, Dijon, France.
5
Infectious Diseases Department, Dijon University Hospital, France; INSERM CIC 1432, module plurithématique, University of Burgundy, Dijon, France. Electronic address:
[email protected]
.
PMID:
32998039
PMCID:
PMC7521398
DOI:
10.1016/j.jinf.2020.09.034
No abstract available
Keywords:
COVID-19; NEWS2; Prediction; SARS-CoV2; Unfavourable event.
Publication types
Letter
Comment
MeSH terms
Aged
COVID-19*
Hospitalization
Humans
SARS-CoV-2
Severity of Illness Index